pindolol has been researched along with propafenone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nanoff, C; Schütz, W | 1 |
| Graziadei, I; Klein, W; Lindner, W; Stark, G; Stark, U; Stoschitzky, K; Zernig, G | 1 |
| Burnett, DM; Gal, J; Nies, AS; Zahniser, NR | 1 |
| Drici, MD; Garraffo, R; Lapalus, P; Morand, P; Sbirrazzuoli, V; Wajman, A | 1 |
| Delise, P; Di Pede, F; Piccolo, E; Raviele, A | 1 |
1 review(s) available for pindolol and propafenone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pindolol and propafenone
| Article | Year |
|---|---|
Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
Topics: Administration, Oral; Adult; Animals; Double-Blind Method; Electrophysiology; Exercise Test; Female; Guinea Pigs; Heart; Heart Rate; Hemodynamics; Humans; Iodocyanopindolol; Male; Pindolol; Propafenone; Radioligand Assay; Random Allocation; Receptors, Adrenergic, beta; Stereoisomerism | 1990 |
10 other study(ies) available for pindolol and propafenone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Iodocyanopindolol; Male; Pindolol; Propafenone; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Stereoisomerism | 1991 |
Propafenone interacts stereoselectively with beta 1- and beta 2-adrenergic receptors.
Topics: Animals; Binding, Competitive; Chromatography, High Pressure Liquid; In Vitro Techniques; Iodine Radioisotopes; Male; Pindolol; Propafenone; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Stereoisomerism | 1988 |
Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmias.
Topics: Adult; Cardiac Complexes, Premature; Cell Membrane; Electrocardiography; Female; Humans; Iodine Radioisotopes; Iodocyanopindolol; Lymphocytes; Male; Middle Aged; Pindolol; Propafenone; Radioligand Assay; Receptors, Adrenergic, beta | 1989 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propafenone; Propiophenones; Tachycardia; Ventricular Fibrillation | 1984 |